Natural killer cell-mediated damage of clinical isolates of mucormycetes

被引:32
|
作者
Schmidt, Stanislaw [1 ]
Schneider, Andreas [1 ]
Demir, Asuman [1 ]
Lass-Floerl, Cornelia [2 ]
Lehrnbecher, Thomas [1 ]
机构
[1] Goethe Univ Frankfurt, Div Pediat Hematol & Oncol, Hosp Children & Adolescents, D-60590 Frankfurt, Germany
[2] Med Univ Innsbruck, Div Hyg & Med Microbiol, A-6020 Innsbruck, Austria
关键词
Invasive fungal disease; natural killer cells; mucormycetes; antifungal activity; immunomodulation; ASPERGILLUS-FUMIGATUS; CANDIDA-ALBICANS; IFN-GAMMA; IMMUNOTHERAPY; GENERATION; BIOLOGY; BIOMASS; RATHER; HYPHAE;
D O I
10.1111/myc.12431
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Haematopoietic stem cell transplant (HSCT) recipients are at high risk for mucormycosis, which has a mortality of up to 90%. The adoptive transfer of Natural killer (NK) cells is a promising therapeutic option in order to improve the reconstitution of host immunity after HSCT and to directly combat the fungal pathogen. As a number of fungal pathogens have developed strategies to evade the innate immune system, we investigated the interaction of human NK cells with various clinical isolates of different species of mucormycetes. Our results show that human IL-2 prestimulated NK cells damaged all mucormycetes tested. The extent of the damage depended, at least in part, on the growth curve characteristics of the individual fungal isolate. All isolates decreased the secretion of interferon- by NK cells to a similar extent. Our data suggest that NK cells damage a wide spectrum of mucormycetes, but that the antifungal effect is higher if NK cells are administered at an early time point of infection.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 50 条
  • [1] Natural Killer Cell-Mediated Immunotherapy for Leukemia
    Allison, Michaela
    Mathews, Joel
    Gilliland, Taylor
    Mathew, Stephen O.
    CANCERS, 2022, 14 (03)
  • [2] Natural killer cell-mediated immunotherapy of hepatoblastoma
    Vatlach, M.
    Pfeiffer, M.
    Seitz, G.
    Ruck, P.
    Heitmann, H.
    Treuner, C.
    Mueller, C. A.
    Steinle, A.
    Lang, P.
    Handgretinger, R.
    Fuchs, J.
    Warmann, S. W.
    KLINISCHE PADIATRIE, 2008, 220 (03): : 210 - 210
  • [3] Natural killer T cell-mediated antitumor immune responses and their clinical applications
    Seino, Ken-ichiro
    Motohashi, Shinichiro
    Fujisawa, Takehiko
    Nakayama, Toshinori
    Taniguchi, Masaru
    CANCER SCIENCE, 2006, 97 (09): : 807 - 812
  • [4] Regulation of natural killer cell-mediated lysis by DAF
    Miyagawa, S
    Kubo, T
    Fukuta, D
    Kusama, T
    Matsunami, K
    Shirakura, R
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 279 - 280
  • [5] Natural killer cell-mediated recognition of human trophoblast
    Biassoni, R
    Bottino, C
    Millo, R
    Moretta, L
    Moretta, A
    SEMINARS IN CANCER BIOLOGY, 1999, 9 (01) : 13 - 18
  • [6] Natural killer cell-mediated immunosurveillance of human cancer
    Malmberg, Karl-Johan
    Carlsten, Mattias
    Bjorklund, Andreas
    Sohlberg, Ebba
    Bryceson, Yenan T.
    Ljunggren, Hans-Gustaf
    SEMINARS IN IMMUNOLOGY, 2017, 31 : 20 - 29
  • [7] Mechanisms of natural killer cell-mediated cellular cytotoxicity
    Prager, Isabel
    Watzl, Carsten
    JOURNAL OF LEUKOCYTE BIOLOGY, 2019, 105 (06) : 1319 - 1329
  • [8] The NKC and regulation of natural killer cell-mediated immunity
    Brown, MG
    Scalzo, AA
    Yokoyama, WM
    MAJOR HISTOCOMPATIBILITY COMPLEX: EVOLUTION, STRUCTURE AND FUNCTION, 2000, : 287 - 301
  • [9] Natural killer cell-mediated innate microvascular rejection
    Thaunat, Olivier
    NATURE REVIEWS NEPHROLOGY, 2024, 20 (08) : 489 - 490
  • [10] Natural killer cell-mediated augmentation of autoantibody production?
    Eckl-Dorna, J.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2012, 92 (04) : 695 - 697